Streetbeat News

Products Services

AMZN

Amazon Clinic has introduced a new feature that allows customers to seek treatment for cough, cold, and flu symptoms virtually. Customers can connect with a licensed clinician through a secure messaging portal or scheduled video visit, receive a personalized treatment plan, and have prescriptions filled by Amazon Pharmacy. The service is available 24/7 and offers cost savings and price transparency for customers.

Portfolio Pulse from Benzinga Newsdesk

October 26, 2023 | 3:57 pm

RSHO

STLA

TSLA

VWDRY

The US manufacturing sector, once a foundational sector, is seeing a potential resurgence driven by the demand for sustainable and green manufacturing. Companies like Tesla and Vestas are leading the way with their sophisticated and technical manufacturing capabilities. Stellantis NV has also made significant strides by opening a state-of-the-art auto plant in Detroit. The Tema American Reshoring ETF is a thematic fund dedicated to investing in companies driving this trend.

Portfolio Pulse from Johnny Rice

October 26, 2023 | 3:36 pm

F

Ford Motor Company (NYSE:F) is testing drone deliveries at Michigan Central, an old train station it is upgrading into an innovation and technology hub. The tests are part of a partnership with the Michigan Department of Transportation to deliver medicine, food, and other items to nearby residents. The drone industry is projected to be worth $50 billion by 2030, and Ford's involvement could open a new business line for the company.

Portfolio Pulse from Chris Katje

October 26, 2023 | 3:21 pm

ABT

The US Food and Drug Administration (FDA) has issued a warning letter to Abbott Laboratories for its product, Similac Probiotic Tri-blend. The FDA states that the product is an unapproved new drug and unlicensed biological product. The product is also adulterated under the Federal Food, Drug, and Cosmetic Act (FD&C Act) because it contains B. infantis (Bb-02), an unsafe food additive, and S. thermophilus (TH-4®), a new dietary ingredient for which there is inadequate information to provide reasonable assurance that such ingredient does not present a significant or unreasonable risk of illness or injury, when used in preterm infants.

Portfolio Pulse from Benzinga Newsdesk

October 26, 2023 | 3:14 pm

BTCUSD

XRPUSD

Cryptocurrency recovery firm Unciphered has offered to help Stefan Thomas, former CTO of Ripple, recover an estimated $244 million worth of Bitcoin from a locked hard drive. The firm claims to have discovered a vulnerability that allows them to access the device. This highlights a broader issue in the crypto world, with nearly 20% of Bitcoin's supply estimated to be inaccessible due to lost access.

Portfolio Pulse from Murtuza Merchant

October 26, 2023 | 2:10 pm

CNVS

Cineverse (NASDAQ: CNVS) has announced that its Midnight Pulp streaming channel is now available through third-party platforms including Amazon Prime Video Channels, The Roku Channel, and Comcast's Xfinity. The company also announced the exclusive North American streaming premiere of MAD CATS on Midnight Pulp on November 21. Midnight Pulp has been formally relaunched powered by Cineverse's proprietary Matchpoint™ Blueprint 2.0 technology, improving the fan experience and content discovery.

Portfolio Pulse from Benzinga Newsdesk

October 26, 2023 | 1:33 pm

AAPL

GOOG

GOOGL

Apple Inc. is reportedly considering the introduction of two budget-friendly MacBook models for the education sector, in a move to compete with Google's Chromebooks. The rumors come amid declining Mac sales and suggest that the launch of such affordable models might take place in the latter half of 2024. However, Apple has not confirmed these plans.

Portfolio Pulse from Benzinga Neuro

October 26, 2023 | 1:33 pm

VCNX

Vaccinex, Inc. (NASDAQ:VCNX) has reported new findings for its lead product, pepinemab, at the Clinical Trials on Alzheimer's Disease (CTAD) Conference. The company has previously reported that pepinemab treatment prevents decline in glucose uptake and significantly slows cognitive decline in Huntington's disease. The new data indicates that pepinemab treatment significantly reduced blood levels of GFAP, a biomarker of reactive astrocytes, providing further evidence of the drug's potential to reverse harmful astrocyte activation and brain inflammation. The company is testing similar effects of pepinemab treatment in an ongoing trial for Alzheimer's disease.

Portfolio Pulse from Benzinga Newsdesk

October 26, 2023 | 1:31 pm

GT

Goodyear Tire & Rubber Company (NASDAQ:GT) and sustainable technology company Visolis have announced a collaboration to produce isoprene, a precursor for synthetic rubber, through the upcycling of biobased materials. The project is supported by a Small Business Innovation Research (SBIR) grant awarded to Visolis. Goodyear is actively seeking sustainable material options and plans to sell a tire with up to 70% sustainable materials this year.

Portfolio Pulse from Benzinga Newsdesk

October 26, 2023 | 1:24 pm

ESMT

InvoiceCloud, an EngageSmart (ESMT) solution, has announced a new integrated solution with Oracle Energy and Water to enhance the utility payment experience for joint customers. The integration will provide Oracle-supported, real-time integration with Oracle Utilities Customer Information Systems (CIS). The aim is to simplify the billing process, reduce staff workloads, accelerate bill payments, and improve the digital payment experience for utility organizations.

Portfolio Pulse from Benzinga Newsdesk

October 26, 2023 | 1:19 pm